BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep 2021;6:2292-304. [PMID: 34250319 DOI: 10.1016/j.ekir.2021.06.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention and treatment. Kidney International 2022. [DOI: 10.1016/j.kint.2022.01.022] [Reference Citation Analysis]
2 Davidovic T, Schimpf J, Abbassi-Nik A, Stockinger R, Sprenger-Mähr H, Lhotta K, Zitt E. Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost. Kidney Int 2021;100:1334-5. [PMID: 34656642 DOI: 10.1016/j.kint.2021.10.006] [Reference Citation Analysis]
3 Karakizlis H, Nahrgang C, Strecker K, Chen J, Aly M, Slanina H, Schüttler CG, Esso I, Wolter M, Todorova D, Jessen S, Adamik A, Ronco C, Seeger W, Weimer R, Sester M, Birk H, Husain-syed F. Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108961] [Reference Citation Analysis]
4 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Liu X, Lin M, Zan J, Hu Y, Wang X, Wu W, Zhou T, Lv J, Zhang H, Yang L, Zhang Z. Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.05.003] [Reference Citation Analysis]
6 Holt SG, Mahmoud S, Ahmed W, Acuna JM, Al Madani AK, Eltantawy I, Zaher WA, Goodier GJ, Al Kaabi NA, Al Obaidli AA. An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates. Nephrology (Carlton) 2021. [PMID: 34569677 DOI: 10.1111/nep.13980] [Reference Citation Analysis]
7 Kronbichler A, Geetha D, Smith RM, Egan AC, Bajema IM, Schönermarck U, Mahr A, Anders HJ, Bruchfeld A, Cid MC, Jayne DRW. The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum. Autoimmun Rev 2021;:102986. [PMID: 34718165 DOI: 10.1016/j.autrev.2021.102986] [Reference Citation Analysis]
8 Carr EJ, Wu M, Harvey R, Wall EC, Kelly G, Hussain S, Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL, Billany RE, Graham-Brown MP, Beckett J, Bull K, Shankar S, Henderson S, Motallebzadeh R, Salama AD, Harper L, Mark PB, McAdoo S, Willicombe M, Beale R; Haemodialysis COVID-19 consortium., Crick COVID Immunity Pipeline. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet 2021:S0140-6736(21)01854-7. [PMID: 34391504 DOI: 10.1016/S0140-6736(21)01854-7] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Füessl L, Lau T, Lean I, Hasmann S, Riedl B, Arend FM, Sorodoc-otto J, Soreth-rieke D, Toepfer M, Rau S, Salihi-halimi H, Paal M, Beuthien W, Thaller N, Suttmann Y, von Gersdorff G, Regenauer R, von Bergwelt-baildon A, Teupser D, Bruegel M, Fischereder M, Schönermarck U. Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients. Vaccines 2022;10:605. [DOI: 10.3390/vaccines10040605] [Reference Citation Analysis]
10 Beilhack G, Monteforte R, Frommlet F, Gaggl M, Strassl R, Vychytil A. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Front Immunol 2021;12:780594. [PMID: 34925359 DOI: 10.3389/fimmu.2021.780594] [Reference Citation Analysis]
11 Tung KT, Peng YS, Hsu SP, Wu HY, Chiu YL, Yang JY, Pai MF, Shu KH, Pan SY, Lu HM, Lin WY, Liao CH, Chu FY, Tsai WC. Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis. Hemodial Int 2022. [PMID: 35411681 DOI: 10.1111/hdi.13011] [Reference Citation Analysis]
12 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Reference Citation Analysis]
13 Bau JT, Churchill L, Pandher M, Benediktsson H, Tibbles LA, Gill S. Acute Kidney Allograft Rejection Following Coronavirus mRNA Vaccination: A Case Report. Transplant Direct 2022;8:e1274. [PMID: 35047661 DOI: 10.1097/TXD.0000000000001274] [Reference Citation Analysis]
14 Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine. Infect Dis Ther 2021. [PMID: 34859359 DOI: 10.1007/s40121-021-00574-9] [Reference Citation Analysis]
15 Benning L, Klein K, Morath C, Bartenschlager M, Kim H, Buylaert M, Reineke M, Töllner M, Nusshag C, Kälble F, Reichel P, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Schaier M, Speer C. Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients. Front Immunol 2022;13:840136. [DOI: 10.3389/fimmu.2022.840136] [Reference Citation Analysis]
16 Stallmach A, Reuken PA, Grunert P, Teich N. [Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management]. Z Gastroenterol 2022. [PMID: 35148564 DOI: 10.1055/a-1744-6697] [Reference Citation Analysis]
17 Benning L, Morath C, Bartenschlager M, Reineke M, Töllner M, Nusshag C, Kälble F, Reichel P, Schaier M, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Speer C. Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared to two-dose BNT162b2 vaccination in kidney transplant recipients. Kidney Int 2021:S0085-2538(21)01169-8. [PMID: 34954213 DOI: 10.1016/j.kint.2021.12.009] [Reference Citation Analysis]
18 Matsunami M, Suzuki T, Fukuda J, Terao T, Ukai K, Sugihara S, Toishi T, Nagaoka K, Nakata M, Ohara M, Yashima J, Kuji H, Matsue K. Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease. Ren Replace Ther 2022;8. [DOI: 10.1186/s41100-022-00402-x] [Reference Citation Analysis]
19 Windpessl M, Heine GH, Becker SL, Scheuer AL, Sester M, Kronbichler A. [The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines]. Dtsch Med Wochenschr 2021;146:1277-82. [PMID: 34553353 DOI: 10.1055/a-1550-7288] [Reference Citation Analysis]
20 Carruthers JE, Wells J, Gupta A, Kallon D, Cox A, Pina N, Yaqoob MM, Rajakariar R. Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Involvement. Front Med 2022;8:817845. [DOI: 10.3389/fmed.2021.817845] [Reference Citation Analysis]
21 Agur T, Ben-dor N, Herman-edelstein M, Steinmetz T, Lichtenberg S, Schneider S, Yahav D, Rozen-zvi B, Zingerman B. Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients. Front Med 2022;9:781888. [DOI: 10.3389/fmed.2022.781888] [Reference Citation Analysis]
22 Yadav AK, Gondil VS, Singla M, Goyal A, Kaushal R, Chauhan M, Jha V. Humoral Response to One and Two Doses of ChAdOx1-S Vaccine in Patients on Hemodialysis. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34544681 DOI: 10.2215/CJN.10170721] [Reference Citation Analysis]
23 Piñana JL, López-Corral L, Martino R, Montoro J, Vazquez L, Pérez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual MJ, Sanz-Linares G, Gago B, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave MT, López-Jimenez J, Marcos-Corrales S, García-Blázquez M, Garcia-Gutiérrez V, Hernández-Rivas JÁ, Saus A, Espigado I, Alonso C, Hernani R, Solano C, Ferrer-Lores B, Guerreiro M, Ruiz-García M, Muñoz-Bellido JL, Navarro D, Cedillo A, Sureda A; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol 2021. [PMID: 34695229 DOI: 10.1002/ajh.26385] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hsu CM, Weiner DE, Manley HJ, Aweh GN, Ladik V, Frament J, Miskulin D, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, Lacson EK Jr. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months. Clin J Am Soc Nephrol 2022:CJN. [PMID: 35144972 DOI: 10.2215/CJN.12250921] [Reference Citation Analysis]
25 Marinaki S, Xagas E, Tsoutsoura P, Katsaros D, Korogiannou M, Boletis IN. Occurrence of Severe SARS-CoV-2 Infection in Fully Vaccinated Solid Organ Transplant Recipients. Transplant Proc 2021:S0041-1345(21)00941-6. [PMID: 35074163 DOI: 10.1016/j.transproceed.2021.12.012] [Reference Citation Analysis]